Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

News & Events

Clinic Update May 2022

PCH Diabetes Service Update We will continue to utilise Telehealth for most appointments and care for the next few weeks at least, but we remain ready to pivot back to face to face care as soon as possible.

News & Events

T1D: Challenge accepted

One step at a time … that’s the message Canadian Sebastien Sasseville wants kids living with Type 1 Diabetes to know when he talks about his T1D journey.

New patient folder

Our new and improved patient folder is a comprehensive resource to help families navigate a new type 1 diabetes diagnosis, now and into the future.

embrace exclusive

Read the latest edition of our magazine, embrace exclusive, right here.

Research

Yarning about yarning as a legitimate method in Indigenous Research

This article demonstrates the credibility and rigor of yarning, an Indigenous cultural form of conversation, through its use as a data gathering tool

People

Amelia Freeman

Amelia Freeman's staff profile at The Kids Research Institute Australia

All through the night

For the parent of a child living with diabetes, sleep no longer represents the relaxing slumber that it used to.

News & Events

The Kids Research Institute Australia welcomes world-leading new laws for vapes

The Kids Research Institute Australia welcomes the Federal Government's stringent vaping reforms that took effect on 1 July 2024.

Research

Start Stronger, Live Longer Resource Manual for Aboriginal Health Workers

This resource kit for Aboriginal health workers is an exciting milestone in the Rio Tinto Aboriginal Health partnership with The Kids Research Institute Australia

Research

A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC

Esophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract with a low 5-year survival rate due to the lack of effective treatment methods. Although therapeutic monoclonal antibodies (mAbs) now play an important role in cancer therapy, effective targeted mAbs are still lacking for ESCC.